DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen (PureTek Corporation)
Welcome to the PulseAid listing for the DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen drug offered from PureTek Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | PureTek Corporation |
NON-PROPRIETARY NAME: | avobenzone, octinoxate, octisalate, titanium dioxide |
SUBSTANCE NAME: | AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2017-02-16 |
END MARKETING DATE: | 0000-00-00 |
DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen HUMAN OTC DRUG Details:
Item Description | DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen from PureTek Corporation |
LABELER NAME: | PureTek Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25; 30; 30; 12.5(mg/mL; mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2017-02-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59088-568_758a637d-10f4-47db-87c2-705dbc593758 |
PRODUCT NDC: | 59088-568 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE Pharmaceutical Manufacturers / Labelers: